Results 91 to 100 of about 22,548 (265)

The potential impact of the fetal genotype on maternal blood pressure during pregnancy. [PDF]

open access: yes, 2014
The heritability of pregnancy-induced hypertension (encompassing both gestational hypertension and preeclampsia) is around 0.47, suggesting that there is a genetic component to its development.
Beardsall, Kathryn   +2 more
core   +1 more source

Timing of Delivery in Preeclampsia: Time to Reconsider?

open access: yes
BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
Rebecca Horgan   +5 more
wiley   +1 more source

Incidence and Risk Factors of HELLP Syndrome in Thai Pregnant Women with Severe Pre-eclampsia [PDF]

open access: yesThai Journal of Obstetrics and Gynaecology, 2008
ObjectivesTo determine the incidence and risk factors of HELLP syndrome in pregnant Thai women with severe pre-eclampsia and to compare pregnancy outcome. DesignCross-sectional study.
Ratcharat Khumsat   +2 more
doaj  

Early preeclampsia and HELLP syndrome in a 20 week pregnant patient [PDF]

open access: yes
The first time Weinstein in 1982 described patients with the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP) in pregnant preeclamptic and eclamptic patients.
Fatemeh Keighobadi Khajeh1 , Gholamreza Faridaalaee2* , Fatemeh,
core  

Progeny, December 2011, Vol. 27, no. 4 [PDF]

open access: yes, 2011
This newsletter from The Department of Public Health about perinatal health care and ...

core  

Placental Protein 13 (PP13) – a placental immunoregulatory galectin protecting pregnancy [PDF]

open access: yes, 2014
Galectins are glycan-binding proteins that regulate innate and adaptive immune responses, and some confer maternal-fetal immune tolerance in eutherian mammals.
Abrahams   +185 more
core   +3 more sources

Characteristics Symptoms of Imminent Eclampsia: A case Referent Study from a Tertiary Hospital in Tanzania [PDF]

open access: yes, 2012
\ud \ud Maternal mortality in developing coun- tries is unacceptably high with eclampsia being con- sistently among the top causes. As yet, primary pre- vention of this complication is not possible since causes of pre-eclampsia are largely unknown and ...
France, John, Muganyizi, Projestine S.
core  

Safety and efficacy of high-dose intravenous iron carboxymaltose vs. iron sucrose for treatment of postpartum anemia [PDF]

open access: yes, 2017
Objective: The purpose of this study is to compare the safety and efficacy of intravenous (IV) high-dose iron carboxymaltose (ICM) with iron sucrose (IS) for the treatment of postpartum anemia. Study design: We performed a retrospective cohort study with
Christoph, Patricia   +3 more
core  

Home - About - Disclaimer - Privacy